Enovis CORP annual report, FY2014

Colfax Corporation 2014 Form 10-K Summary

Filing identity: The provided filing is for Colfax Corporation, not Enovis Corporation. It covers the fiscal year ended December 31, 2014; the report was filed February 17, 2015. Colfax operated through gas and fluid handling and fabrication technology segments, marketed primarily under Howden, ESAB, Victor and Colfax Fluid Handling brands.

Business Context and Reporting Period

  • Colfax is a diversified global industrial manufacturer serving power generation, oil and gas, petrochemical, mining, marine, defense, general industrial, welding and cutting markets.
  • Approximately 76% of sales were derived from operations outside the United States, and approximately 48% of sales were shipped to emerging markets.
  • The company had 18,351 associates at December 31, 2014, compared with 17,759 at December 31, 2013.
  • The April 2014 acquisition of Victor Technologies materially affected year-over-year comparability.

Financial Performance and Key Metrics

Metric20142013Change
Net sales$4.624 billion$4.207 billion+9.9%
Gross profit$1.479 billion$1.306 billion+13.2%
Gross margin32.0%31.0%+100 bps
Operating income$409.6 million$406.4 million+0.8%
Operating margin8.9%9.7%Down
Net income$420.3 million$209.1 million+101.0%
Net income available to common shareholders$370.2 million$158.2 million+134.0%
Diluted EPS$3.02$1.54+96.1%
Cash flow from operations$385.8 million$362.2 million+6.5%

Reported net income benefited substantially from a $145.4 million non-cash tax benefit arising from the reassessment of deferred tax asset realizability following the Victor acquisition and a $21.8 million tax benefit related to the resolution of uncertain tax positions.

Segment Performance

Segment2014 Sales2014 Operating IncomeOperating Margin
Gas and fluid handling$2.330 billion$254.2 million10.9%
Fabrication technology$2.295 billion$265.8 million11.6%
  • Gas and fluid handling sales increased 10.7%, primarily from acquisitions, while existing-business sales declined $31.3 million. Segment margin declined from 12.9% to 10.9%, partly due to higher selling, general and administrative costs, impairment charges and restructuring activity.
  • Fabrication technology sales increased 9.1%, primarily due to Victor, partly offset by a $47.7 million decline in existing-business sales and adverse foreign exchange. Segment margin improved from 10.4% to 11.6%.
  • Gas and fluid handling backlog was $1.4 billion at year-end, down from $1.6 billion at December 31, 2013.

Liquidity, Debt and Cash Flow

  • Cash and cash equivalents were $305.4 million at December 31, 2014, compared with $311.3 million at year-end 2013. Approximately $279.4 million was held outside the United States.
  • Total debt was $1.539 billion, including $1.133 billion of term loans, $326.3 million of revolving and other borrowings, and $80.0 million outstanding under a new receivables financing facility.
  • Weighted-average borrowing cost under the Deutsche Bank Credit Agreement was 1.94%, excluding amortization of original issue discount and deferred financing fees.
  • Revolving credit availability was $674.9 million, including $199.9 million available under a letter-of-credit subfacility. Additional letter-of-credit facilities had $699.1 million of capacity, with $381.2 million outstanding.
  • Operating cash flow was $385.8 million. Capital expenditures were approximately $81.3 million, and acquisition cash outflows were $948.8 million, principally for Victor.
  • Management stated that available liquidity was adequate to fund operations for the next twelve months. The company was in compliance with its debt covenants at year-end.

Material Changes Versus the Prior Comparable Period

  • Victor was acquired for net cash consideration of $948.8 million and contributed $347.3 million of 2014 sales and $35.9 million of net income available to common shareholders from the acquisition date through year-end.
  • Common stock issuance generated approximately $613.9 million of net financing proceeds, and the Series A preferred stock was converted into 12.2 million common shares. The company paid a $19.6 million preferred-stock conversion inducement expense.
  • Interest expense fell to $51.3 million from $103.6 million, primarily because 2013 refinancing-related write-offs did not recur and borrowing rates were lower.
  • Restructuring charges increased to $58.1 million from $35.5 million. Management expected approximately $50 million of additional restructuring charges during 2015.
  • Foreign currency translation reduced other comprehensive income by $356.2 million, contributing to accumulated other comprehensive loss of $443.7 million at year-end.
  • Goodwill increased to $2.873 billion, and net intangible assets increased to $1.044 billion, reflecting acquisitions. The company recorded $13.4 million of identifiable intangible-asset impairment and $4.6 million of fixed-asset impairment and restructuring-related charges.

Guidance, Outlook, Risks and Unusual Items

  • Management expected long-term organic growth from expanded product offerings, customer growth and the application of the Colfax Business System. It also expected continued growth through strategic acquisitions.
  • Management anticipated adverse foreign-exchange effects beginning in the first quarter of 2015 due to a stronger U.S. dollar.
  • Key risks include cyclical industrial demand, oil and commodity-price declines, acquisition integration, restructuring execution, foreign exchange, raw-material costs, international operations, competition, cyber risk and restrictive debt covenants.
  • Asbestos-related liabilities were $396.3 million, offset by approximately $399.6 million of current and long-term insurance assets and receivables. The company funded $60.3 million expected to be reimbursed by excess insurers, and quarterly cash funding could reach approximately $10 million until litigation is resolved.
  • Asbestos claims remained significant: 21,681 unresolved claims at year-end 2014 versus 22,393 at year-end 2013. The company recorded a $6.9 million pre-tax asbestos-related charge in 2014.
  • Defined benefit plans were underfunded by approximately $331.5 million in aggregate at year-end 2014, and estimated 2015 contributions were $45.1 million.
  • The company faced a derivative lawsuit concerning the preferred-stock conversion and cash payment to the BDT Investor. Management did not expect the litigation to have a material adverse effect, but the matter remained unresolved.
  • Victor was excluded from management’s internal-control assessment because it was acquired in April 2014. Victor represented 17% of total assets, 27% of net assets, 8% of sales and 10% of net income available to common shareholders for 2014. The auditors nevertheless issued an unqualified opinion on internal control over financial reporting.

Most Important Facts for Investors to Verify

  • Confirm the correct issuer: the supplied filing is Colfax Corporation, not Enovis Corporation.
  • Separate recurring operating performance from the $145.4 million non-cash tax benefit and other unusual tax items.
  • Assess Victor’s post-acquisition sales, profitability, integration costs and contribution to leverage.
  • Review debt maturities, covenant thresholds, refinancing assumptions and available revolving capacity.
  • Evaluate asbestos insurance recoverability, pending insurer appeals and the potential for cash funding beyond recorded liabilities.
  • Monitor restructuring charges, impairment risks and the substantial goodwill and intangible-asset balances.
  • Assess the effect of currency movements, particularly the stronger U.S. dollar, on international sales and margins.
  • Review pension funding requirements, purchase obligations, letters of credit and other contractual commitments.